Dianthus Therapeutics, Inc. · NASDAQ:DNTH

BCLS Fund III Investments, LP reported a 7.50% stake in Dianthus Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

BCLS Fund III Investments, LP reported a 7.50% stake in Dianthus Therapeutics, Inc., 2,482,250 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
7.50%
Shares
2,482,250
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BCLS Fund III Investments, LP7.50%2,482,250

Source

View original at SEC

Related